Countries covered: United States
Industry Risk Ratings Synopsis
This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating environment'.
The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising from the expected future performance of the industry (growth risk) and risk arising from forces external to the industry (external sensitivity risk).
This approach is new in that it analyses non-financial information surrounding each industry. Industries are scored on a 9-point scale, where 1 represents the lowest risk and 9 the highest. The Industry Risk score measures expected Industry Risk over the coming 12-18 months.
Industry Definition
Biotechnology is the application of science and technology to living organisms as well as parts, products and models thereof, to alter living or non-living materials for the production of knowledge and biotechnology products and services. The definition of biotechnology as used by the US Census Bureau and the National Science Foundation is: the application of molecular and cellular processes to solve problems, conduct research, and create goods and services. Biotechnology includes a diverse collection of technologies that manipulate cellular, sub-cellular, or molecular components in living things to make products or discover new knowledge about the molecular and genetic basis of life, or to modify plants, animals and micro-organisms to carry desired traits. Such technologies include, but are not limited to: genetic engineering (e.g. recombinant DNA, gene therapy, cloning, antisense); hybridoma technology (to produce monoclonal antibodies); polymerase chain reaction or PCR amplification; gene mapping; DNA sequencing; restriction fragment length polymorphism (RFLP) analysis; and protein engineering.
Report Contents
Risk Overview
The Risk Overview chapter includes sections on Industry Definition and Activities, Industry Risk Score and Risk Rating Analysis. The Industry Definition and Activities section provides a detailed definition of the activities carried out by operators in this industry as defined in NAICS. A list of the primary activities of the industry is also included. The Industry Risk Score section provides the Overall Industry Risk Score as well as the Risk Scores for each of the three types of risk covered that combine to form the Overall Industry Risk Score. These three types of risk are Structural Risk, Growth Risk and External Sensitivity Risk. The Risk Rating Analysis section discusses the underlying factors contributing to the Overall Industry Risk Score.
Structural Risk
The Structural Risk chapter looks at risk arising from within the industry itself and provides a detailed discussion of the industry’s level of exposure to seven key indicators. These key indicators are Barriers to Entry, Competition, Industry Exports, Industry Imports, Level of Assistance, Life Cycle Stage and Volatility of Industry. The Overall Structural Risk Score is a weighted aggregation of these seven key indicators. Each of the key indicators is discussed in detail in this section.
Growth Risk
The Growth Risk chapter looks at risks arising from the expected future performance of the industry. The Overall Growth Risk Score is determined by amalgamating the scores for Recent Industry Growth and Forecast Industry Growth. Detailed analysis is provided discussing the reasons for the growth scores of both.
Sensitivity Risk
The Sensitivity Risk chapter looks at risks arising from forces (sensitivities) external to the industry. The Overall External Sensitivity Risk Score is determined by identifying the most significant (up to 6) external factors and weighting them to represent how significant each sensitivity is to the performance of the industry. Examples of External Sensitivities are Exchange Rates, Interest Rates, Commodity Prices and Government Regulations. There is also a detailed analysis of the affect each of the sensitivities has on the industry, including charts and data tables where appropriate.
Industry Risk and Industry Risk Scoring Methodology
This chapter provides an overview of how IBISWorld defines Industry Risk and discusses the methodology used to arrive at an Industry Risk Score. There is also a table that provides a definition of the seven levels of Industry Risk.
NN001 - Biotechnology in the US
32541 - Pharmaceutical & Medicine Manufacturing in the US
62151 - Diagnostic & Medical Laboratories in the US
32531 - Fertilizer Manufacturing in the US
31111 - Animal Food Production in the US
31191 - Snack Food Production in the US
33911a - Medical Instrument & Supply Manufacturing in the US
33911b - Ophthalmic Lens Manufacturing in the US
54171 - Scientific Research & Development in the US
54194 - Veterinary Services in the US
Related Reports:
Biotechnology Sector
Monoclonal antibodies: 2009 update
Biotech Business - November 2009
Biotech Equipment Update - November 2009
Biotech Financial Reports - November 2009
Worldwide Biotech - November 2009
Biotechnology (Pharmaceuticals) Report
Opportunities in Human Embryonic Stem Cell (hESC) Products
Global Stem Cell and Advanced Technologies Market
Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy
|
(0 items)
